User Evaluation of the Peristomal Skin Condition in Ostomates Using ConvaTec Moldable Technology™
OSMOSE
Observational User Evaluation of the Peristomal Skin Condition in Ostomates Using ConvaTec Moldable Technology™
1 other identifier
observational
600
1 country
1
Brief Summary
The primary aim of this study is to demonstrate the maintenance of healthy peri-stomal skin over a two month period in subjects who use ConvaTec Moldable Technology™ Skin Barriers as part of their standard protocol of care following surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 3, 2015
CompletedFirst Posted
Study publicly available on registry
July 16, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedJuly 16, 2015
July 1, 2015
1.2 years
July 3, 2015
July 15, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Peri-stomal skin condition at 8-15 days following the application of the barrier.
Using SACs scale to determine incidence and severity of lesions
8-15 days
Secondary Outcomes (2)
Peristomal skin condition in ostomates at 1 month (± 15 days) following the application of the barrier.
1 month (± 15 days)
Peristomal skin condition in ostomates at 2 months (± 15 days) following the application of the barrier.
2 months (± 15 days)
Interventions
Eligibility Criteria
Subjects with colostomy, ileostomy or urostomy
You may qualify if:
- Subjects who are 18 years old and older.
- Subjects who agree to participate in the evaluation and who have signed the informed consent form.
- Subjects presenting with a stoma (ileostomy, colostomy or urostomy).
- Subjects for whom ConvaTec Moldable Technology™ per package insert, within the context of routine clinical care is used as the first long-term (within 7 days of ostomy surgery) system following surgery and who have intact peristomal skin (healthy or SACs L1).
You may not qualify if:
- Subjects who, according to the investigator, have cognitive problems that prevent them from answering a questionnaire or for whom the evaluation could be a problem.
- Subjects who are in a simultaneous clinical evaluation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ConvaTec Inc.lead
Study Sites (1)
Voivodeship Specialistic Hospital in Gorzow Wlkp.
Gorzów Wielkopolski, Lubusz Voivodeship, 66-400, Poland
Study Officials
- STUDY DIRECTOR
Kim Peters, BSc (Hons)
Sponsor GmbH
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 3, 2015
First Posted
July 16, 2015
Study Start
June 1, 2015
Primary Completion
August 1, 2016
Last Updated
July 16, 2015
Record last verified: 2015-07